ZHANG Hai-feng;FANG Xi-jing;BI Lan;Wuhan Institute of Biological Products Co., Ltd.;Objective To identify the expression of specific recombinant BCG-BE1726 D protein(rBCG-BE1726D) and evaluate its immunogenicity in mice. Methods Freeze-dried BCG-SSI and rBCG-BE1726 D strains were subjected to expand cultivation of which the supernatant was collected by ultrafiltration concentration, while bacteria by ultrasoniction and centrifugation, and determined for specific proteins by Western blot. BALB / c mice were immunized s.c. with rBCGBE1726 D and BCG strains, of which splenic lymphocytes were isolated 6 weeks later, then determined for the secretion level of interferon γ(IFNγ) by ELISPOT and ELISA, and for percentages of CD4~+ amd CD8~+ T lymphocytes by flow cytometry. Results Ag85 B, ESAT-6 and RV2626c proteins were detected in rBCG-BE1726 D strain, while only Ag85 B in BCG-SSI. After stimulation with Ag85 B, the number of cell spots in BCG-SSI and rBCG-BE1726 D groups were significantly higher than those in PBST control group(P < 0. 05). However, after stimulation with PPD, the number of cell spots in rBCG-BE1726 D group was significantly higher than those in BCG-SSI and PBST control groups(P < 0. 000 1).No significant differences were observed in the numbers of cell spots produced by stimulation with ESAT-6, Rv2626 c,Rv1733c and RpfD in various groups(P > 0. 05). After stimulation with Ag85 B, the secretion of IFNγ in BCG-SSI and rBCG-BE1726 D groups were significantly higher than that in PBST control group(P < 0. 05). However, after stimulation with PPD, the secretion level of IFNγ in rBCG-BE1726 D group showed no significance with that in BCG-SSI group(P >0. 05). The secretion levels of IFNγ after stimulation with ESAT-6, Rv2626c, Rv1733c and RpfD in various groups showed no significant difference(P > 0. 05). The total percentage of CD4~+ and CD8~+ cells as well as ratio of CD4~+ to CD8~+ T lymphocytes in rBCG-BE1726 D group were significantly lower, while the percentage of CD8~+ T lymphocytes was significantly higher, than those in BCG-SSI and PBST control groups(P < 0. 05). Conclusion Recombinant BCGBE1726 D showed high immunogenicity, which enhanced the immune response level of BALB / c mice significantly.However, the immunogenicity of r BCG-BE1726 D showed no obvious advantages as compared with BCG-SSI, so the protection of this vaccine should be further studied.
2016 02 v.29 [Abstract][OnlineView][Download 356K]